Glycan supplement study for Crohn's disease after surgery
Part of Digestive system clinical trials.
This trial tests whether a glycan supplement can prevent Crohn's disease from coming back after surgery to remove the diseased part of the small and large intestine. It may help people who have had this specific surgery and are not taking certain other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with Crohn's disease affecting the last part of the small intestine (ileum) or both the ileum and colon.
- You have had surgery to remove the diseased part of your ileum and the valve between the small and large intestine (ileocecal resection).
- You are not currently taking antibiotics, aminosalicylates, thiopurines, methotrexate, biologics, or other targeted small-molecule drugs after surgery to prevent the disease from coming back.
- You do not have a history of cancer (except skin cancer), poorly controlled diabetes, bleeding disorders, or an allergy to shellfish or glycan products.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral treatment called EXL01 to see if it can prevent Crohn's disease from coming back after surgery to remove part of the small and large intestine. It may be an option if you are not planning to use strong immune-suppressing drugs (except anti-TNF) in the next 6 months.
This trial tests if checking a stool marker (fecal calprotectin) early after surgery can guide treatment with ustekinumab to prevent Crohn's disease from coming back. It's for people who had certain bowel surgery and have at least one risk factor for recurrence.
This trial compares different biologic medications to see which best prevents Crohn's disease from coming back after intestinal surgery. It may help you if you have had surgery for Crohn's and are starting a biologic drug soon after.
This study looks at what happens to people with Crohn's disease after they have surgery to remove a diseased part of their intestine. The goal is to find patterns or signs that might help predict whether the disease will come back, which could help doctors plan better follow-up care.
This trial tests a specific laparoscopic (keyhole) surgery technique for Crohn's disease affecting the last part of the small intestine. It aims to see if removing more of the fatty tissue around the bowel leads to better outcomes. If you have Crohn's disease needing surgery in this area, you may be eligible.
This study tests an oral supplement called N-acetylglucosamine (a natural sugar) to see if it can help control Crohn's disease. It involves taking the supplement and attending follow-up visits, including some genetic testing.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.